Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Agilent Technologies Inc. (NYSE: A) SEC filings page provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8-K, annual and quarterly reports when available, and other filings that describe Agilent’s financial condition, governance changes, and capital markets activities.
Agilent uses Form 8-K to report material events such as quarterly financial results and executive leadership changes. For example, the company has filed 8-Ks to furnish earnings press releases for fiscal quarters, explaining revenue, net income, segment performance for the Life Sciences and Diagnostics Markets Group, Agilent CrossLab Group, and Applied Markets Group, and to discuss the use of non-GAAP financial measures. Separate 8-K filings describe the resignation of a chief financial officer, the appointment of an interim CFO, and the subsequent appointment of a new senior vice president and chief financial officer, including related compensation and equity awards.
Through its filings, Agilent explains why it presents non-GAAP financial information, stating that these measures are intended to provide meaningful supplemental insight into operational performance and to facilitate comparisons with historical results and other companies. The company notes that non-GAAP figures exclude items such as restructuring and amortization, are monitored alongside GAAP results, and may differ from similar measures used by other issuers.
On Stock Titan, these SEC filings are updated from EDGAR and can be paired with AI-powered summaries that highlight key points, such as changes in leadership, segment trends, and the rationale behind non-GAAP adjustments. Users can quickly locate current reports, review disclosures about executive appointments and compensation arrangements, and understand how Agilent communicates its financial performance and governance decisions to regulators and investors.
Agilent Technologies, Inc. (A) reported an initial statement of beneficial ownership for a Senior Vice President. The reporting officer is identified as an executive (Senior Vice President) and, according to the filing, holds 0 shares of Agilent common stock in direct ownership and reports no derivative securities such as options or warrants. The form is filed by one reporting person, with a power of attorney noted in the remarks.
Agilent Technologies, Inc. (A) reported an insider equity transaction by a Senior Vice President in a Form 4. On 11/14/2025, the executive surrendered 27 shares and 51 shares of common stock back to Agilent at a price of $146.82 per share. These shares were withheld to cover tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. After these routine tax-related transactions, the reporting person beneficially owned 5,769.0318 and then 5,718.0318 shares of Agilent common stock directly.
Agilent Technologies, Inc. reported an insider equity transaction by a senior executive. A Senior Vice President filed a Form 4 showing two tax-related share surrenders on 11/14/2025. The executive surrendered 44 shares and 56 shares of Agilent common stock to the company to cover tax liabilities arising from the vesting of restricted stock units, in transactions reported under Rule 16b-3.
After these transactions, the executive beneficially owned 19,163.9266 shares of Agilent common stock directly and 2,607.6856 shares indirectly through a spouse. The holdings include shares acquired under Agilent’s dividend reinvestment plan and its Employee Stock Purchase Plan, which were obtained in transactions exempt from Section 16 reporting rules.
Agilent Technologies (A) reported insider share transactions by its President and CEO related to equity compensation taxes. On 11/14/2025, the executive surrendered 203 shares of common stock to Agilent at a price of $146.82 per share to cover tax liabilities from vested restricted stock units, leaving 33,245 shares beneficially owned afterward. On the same date, the executive surrendered an additional 276 shares at $146.82 per share for the same tax purpose, resulting in 32,969 shares beneficially owned following these transactions. These are routine tax-withholding transactions under Rule 16b-3 rather than open-market purchases or sales.
Agilent Technologies, Inc. executive reports tax-related share surrender
An Agilent Technologies (A) Senior Vice President reported two small transactions in company common stock on 11/14/2025. The reporting person surrendered 37 shares and 58 shares of Agilent common stock to the company at a price of $146.82 per share to cover tax liabilities arising from the vesting of restricted stock units, in accordance with Rule 16b-3. After these transactions, the executive directly beneficially owns 8,064 shares of Agilent common stock.
Agilent Technologies (A)11/14/2025, Gonsalves surrendered 77 shares and 99 shares of Agilent common stock to the company to cover tax liabilities arising from the vesting of restricted stock units, with both transactions priced at $146.82 per share under Rule 16b-3. After these tax-withholding transactions, he beneficially owned 30,924.6872 shares directly. The filing notes that this direct amount includes 52.6440 shares acquired through Agilent’s dividend reinvestment plan and 76.3520 shares acquired via an employee stock purchase plan in transactions exempt from short-swing profit rules. In addition, 40.192 shares are held indirectly through the Gonsalves Trust, for which Rodney and Rochelle Gonsalves serve as trustees.
Agilent Technologies insider plans a small Rule 144 stock sale. The notice reports that Padraig Mcdonnell intends to sell 911 shares of Agilent common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of 130,491.64. The filing notes 283,500,427 common shares outstanding. The shares to be sold were acquired via restricted stock vesting from the issuer on 11/15/2024 and 11/16/2024, in amounts of 523 and 388 shares as compensation.
Over the past three months, the same seller disposed of 2,000 Agilent common shares on 09/02/2025 for gross proceeds of 249,760.00 and 12,490 shares on 11/12/2025 for gross proceeds of 1,873,500.00. The signer represents that they do not know of any material adverse information about Agilent’s current or prospective operations that has not been publicly disclosed.
Agilent Technologies (A) insider transaction: The company’s President and CEO, also a director, exercised 12,490 stock options at $109.86 per share on 11/12/2025 and sold 12,490 common shares at $150 the same day. Following these transactions, the reporting person directly owned 33,448 shares.
The activity was conducted under a Rule 10b5-1 plan adopted on March 28, 2025. The options were granted under the 2018 Stock Plan, originally awarded on November 17, 2020, and became exercisable in four equal annual installments beginning one year after grant, with an expiration date of November 17, 2030.
A filed a Form 144 reporting a proposed sale of 12,490 shares of common stock with an aggregate market value of $1,873,500. The planned transaction lists Fidelity Brokerage Services LLC as broker and the NYSE as the exchange, with an approximate sale date of 11/12/2025.
The shares were acquired on 11/12/2025 from the issuer via an option granted on 11/17/2020, with cash payment. Over the past three months, Padraig Mcdonnell sold 2,000 shares on 09/02/2025 for gross proceeds of $249,760.
Agilent Technologies appointed Adam S. Elinoff as Senior Vice President and Chief Financial Officer, effective November 17, 2025, replacing interim CFO Rodney Gonsalves, who continues as Vice President, Corporate Controller and Principal Accounting Officer.
The compensation package includes a base salary of $700,000 and eligibility for an annual bonus targeted at 80% of base salary. Equity awards comprise fiscal 2025 RSUs with a target value of $1,100,000 and performance-based RSUs for the fiscal 2026–2028 period with a target value of $1,650,000, effective November 18, 2025. The Committee also approved a one-time cash bonus of $800,000 subject to repayment if employment ends within 12 months, plus sign-on RSUs targeted at $560,000 and performance-based RSUs targeted at $840,000.
RSUs vest over four years. Performance-based RSUs vest on October 31, 2028 with payout ranging from 0% to 200% based on Company performance. Agilent furnished a press release as Exhibit 99.1.